gastroenterology
Data sets up ulcerative colitis expansion for BMS’ MS drug Zeposia
Phil Taylor
Bristol-Myers Squibb, gastroenterology, immunology, Ozanimod, ulcerative colitis, Zeposia
0 Comment
News/ News/ Sales and Marketing
Despite biosims, ulcerative colitis drugs still cost too much; ICER
Phil Taylor
AbbVie, gastroenterology, Humira, inflammatory bowel disease, Johnson & Johnson, Merck & Co, Pfizer, Takeda, ulcerative colitis
0 Comment
Takeda posts surprise profit a year after Shire mega-merger
Richard Staines
gastroenterology, M&A, neurology, Oncology, Rare diseases, Shire, Takeda
0 Comment
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Phil Taylor
C. diff infections, clinical trial, Ferring, gastroenterology, infectious disease, microbiome, Rebiotix
0 Comment
Market Access/ News/ News/ News/ News/ Patients/ Sales and Marketing
FDA says all ranitidine drugs should be recalled on safety concerns
News/ News/ R&D/ Top stories
Takeda buys US biotech PvP Biologics for $330 million
Richard Staines
coeliac disease, gastroenterology, M&A, R&D, Takeda
0 Comment
Takeda buys coeliac drug licence from COUR Pharmaceuticals
Richard Staines
coeliac disease, gastroenterology, Takeda
0 Comment
AZ sells rights to gastro drug Losec to Cheplapharm in $309m deal
Richard Staines
AstraZeneca, Cheplapharm, gastroenterology
0 Comment